Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03642379
Other study ID # Peer Recovery Support
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 10, 2018
Est. completion date September 10, 2019

Study information

Verified date October 2018
Source University of Rochester
Contact David S Goede, DNP
Phone 585-275-5276
Email david_goede@urmc.rochester.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Develop and implementation an addiction recovery support program for cardiac surgery patients admitted with a diagnosis of infective endocarditis secondary to IV drug addiction.


Description:

Patients admitted with active IE secondary to IV drug use require a myriad of services and will remain hospitalized for a minimum of six weeks. During their hospitalization, infectious disease service assists in developing a treatment plan for the active infection, neurosurgery service evaluates and develops a plan to treat any sequelae of endocarditis, toxicology service develops a treatment plan to manage the detoxification, and cardiac surgery service develops a treatment plan for the infected valve. In spite of all these services, there is no dedicated service to address the patient's substance use disorder (SUD). This missed opportunity to begin addressing the substance use disorder potentially impairs the patient's ability to engage in the first steps towards sobriety. Ideally, a recovery support model of care would be available to assist these patients during their hospitalization to transition from active addiction into the early phases of recovery from addiction.

This is a single center/single unit (7-3600) exploratory study to examine the efficacy of three interventions on a subject's SOCRATES 8D score at time of discharge, at three months, and at six months. A convenience sample of all patients admitted to 7-3600 who meet the inclusion criteria for this study will be approached and provided information related to this study. Once entered into the study, the subjects will continue in the study through their hospitalizations and up to 90 days post hospitalization.


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date September 10, 2019
Est. primary completion date September 10, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

All patients considered for this program must meet the following criteria:

1. Must be at least 18 years of age and able to provide consent

2. Must speak/read/understand English

3. Currently hospitalized and physically located on 7-3600 unit

4. Followed by or on the Cardiac Surgery service

5. Have a diagnosis of Endocarditis associated with recent or remote intravenous drug use (IVDU)

6. Alert and oriented to person, place, time, and events leading up to hospitalization

7. Able to carry on a coherent conversation

8. Clinical Opiate Withdrawal (COW) score of less than or equal to 5 with no adjunctive (opioids) medication use within past 24 hours a. If COW score is greater than five or adjunctive medications have been used within the previous 24 hours, the patient will be re-evaluate every 24 hours until score is less than or equal to five and no adjunctive medications used within the previous 24 hours

Exclusion Criteria:

1. Under the age of 18 years old

2. Unable to speak/read/understand English

3. Hospitalized but not on 7-3600

4. Does not have a diagnosis of endocarditis associated with IVDU

5. Not followed by or on the Cardiac Surgery service

6. Not Alert or oriented or unable to carry on a coherent conversation

7. COW score that is greater than five or adjunctive medications have been used within the previous 24 hours (see inclusion criteria)

Study Design


Intervention

Behavioral:
Peer Advocate
Provide NA book to review during hospitalization

Locations

Country Name City State
United States University of Rochester Medical Center Strong Memorial Hospital Rochester New York

Sponsors (1)

Lead Sponsor Collaborator
University of Rochester

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Abstinence from drug use based on negative drug screen Demonstrate negative drug screens done randomly by urine testing during their hospitalization. Enrollment up to 60 days post-discharge
Other Engagement in the Peer Recovery Support Program Actively engage in the program as defined by meeting with a Peer Support Volunteer at least two times prior to discharge, and or use of resilience journal, and or review of Narcotics Anonymous book Count of number of meetings in 2 weeks
Other Planning for outpatient recovery program Actively contact at least one outpatient recovery program that they might enroll in by study completion (information about recovery programs to be provided by unit SW). 1 week prior to discharge
Primary Readiness to change Personal Drug Use Questionnaire SOCRATES 8D survey scores from admission to program to post discharge. A 19 item scale that measures 3 domains, Recognition of a drug problem, Ambivalence to change, and Taking Steps towards recovery. Each item is measured on a 5 point Likert scale. Scoring on the domains indicates the individual readiness to pursue sobriety. Score range for Recognition is 7-35. High score (35) correlates that they do identify they have a problem related to substance use while a low score (<30) indicates denial of a problem. The Ambivalence score range is between 4-20. A high score (>17) on this domain indicates ambivalence or uncertainty of change while a low score (<8) indicates that they do know that they have a drinking problem. Taking Steps score range is between 8-40. High scores (>36) in this domain indicate that the individual is taking steps on to change their behavior while low scores (<30) indicate that they are not currently doing things to change Change in scores from end of intervention (2 weeks) to 30, 60, and 90 days post-intervention
Secondary Participation in peer recovery support program Participate in follow up phone call with completion of SOCRATES 8D survey at 30, 60 and 90 days post discharge Change in scores from end of intervention (2 weeks) to 30, 60, 90 days post-intervention
See also
  Status Clinical Trial Phase
Completed NCT05660434 - Using Aromatherapy in Substance Use Disorder N/A
Active, not recruiting NCT05338268 - Substance Use and Loneliness N/A
Completed NCT04098614 - Barriers to Substance Use Disorder Recovery N/A
Completed NCT03954184 - E-health Implementation (Iowa) N/A
Completed NCT03590106 - Cardiac Surgery Peer Recovery Support Program N/A
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Recruiting NCT06273228 - Parenting Young Children in Pediatrics N/A
Recruiting NCT05327504 - Written Exposure Therapy for Veterans With SUD and PTSD N/A
Terminated NCT03517111 - The Impact of a Parenting Intervention on Latino Youth Health Behaviors N/A
Completed NCT04284813 - Families With Substance Use and Psychosis: A Pilot Study N/A
Completed NCT04401215 - Technologically-Augmented Referrals to Mitigate Addiction Consequences N/A
Not yet recruiting NCT06187701 - Co-Active Therapeutic Theatre (Co-ATT) for Dual-Diagnosis Patients N/A
Not yet recruiting NCT06163651 - Evaluating a One-Year Version of the Parent-Child Assistance Program N/A
Recruiting NCT04296604 - Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations N/A
Active, not recruiting NCT02382042 - Intensive Referral Intervention to Improve Substance Use Disorder Treatment Outcomes Among Rural and Highly Rural Veterans N/A
Completed NCT01237366 - Study Targeting Affect Regulation Phase 1/Phase 2
Terminated NCT01356667 - Drum-Assisted Therapy for Native Americans N/A
Completed NCT00708890 - Twelve Step Based Self-help Groups for Substance Related Disorders N/A
Active, not recruiting NCT04048850 - Zepatier in Patients With Substance Use
Recruiting NCT05976646 - Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion Phase 1/Phase 2